AES Semigas


22 October 2020

Modulight adds Aixtron AIX 2800G4-TM MOCVD system

Deposition equipment maker Aixtron SE of Herzogenrath, near Aachen, Germany says that Modulight Inc of Tampere, Finland (an ISO-certified manufacturer of biomedical lasers and systems for genetics, oncology and ophthalmology) has added an AIX 2800G4-TM metal-organic chemical vapor deposition (MOCVD) system to its existing in-house epitaxial wafer production capabilities.

The system will be installed in Modulight’s fully owned fab, where the firm conducts high-volume manufacturing of gallium arsenide (GaAs)- and indium phosphide (InP)-based devices. Modulight is currently expanding the fab’s production space by 1000m2. The new system will allows it to guarantee supply, and give it the control to provide tailor-made solutions.

“The quality requirements in this sensitive application sector are extremely high. Therefore, the epiwafers must have highest deposition uniformity control, lowest particle count, best yield, and lowest production cost,” says Modulight’s chairman & CEO Seppo Orsila. “The MOCVD technology of Aixtron guarantees us the fulfilment of these high demands on epiwafers, and helps us to benefit from higher scalability,” he comments.

Modulight’s product range includes various types of lasers from visible to infrared (400-2000nm) with output power levels from milliwatts to hundreds of watts. The firm has over 20 years’ experience in designing and manufacturing FDA- and CE-approved lasers and providing value-added solutions to optical applications. Its lasers are used for medical, industrial and environmental applications due to their high efficiency and brightness compared with conventional light sources, the possibility of contactless material processing and monitoring from a distance, and shorter cycle times due to fast processing.

The lasers are also used in the automotive industry, for example for reliable distance measurement and autonomous driving.

Modulight’s lasers are also used in medical applications ranging from surgery to non-invasive therapeutic procedures, particularly in oncology, ophthalmology and genetics. Tailoring the wavelength adds versatility and offers a high degree of customization of output power and beam delivery. The firm says that its laser platform is favored by institutes and companies working in oncology due to its extreme versatility and simplicity of use.

“Due to the advantages of medical lasers, this market is growing very strongly,” notes Aixtron president Dr Bernd Schulte. “In the coming years, the billion-dollar mark is expected to be exceeded,” he adds. “However, excellent laser quality is essential for medical lasers. Modulight is one of the world’s leading specialists in the laser market, especially for medical applications,” he comments.

Tags: Aixtron Modulight





Book This Space